56
Participants
Start Date
January 23, 2017
Primary Completion Date
January 21, 2021
Study Completion Date
January 21, 2021
Mirabegron
"Study A The maximum tolerated dose up to a maximum of 300 mg per day for 26 weeks.~Study B One single dose of 300 mg at day one followed by 150 mg x 2 for 1 week (8-11 days)."
Rigshospitalet, Copenhagen
Bispebjerg-Frederiksberg Hospital, Denmark
UNKNOWN
Hillerød hospital, Denmark
UNKNOWN
Herlev Hospital
OTHER
Hvidovre University Hospital
OTHER
Bornholm Hospital, Denmark
UNKNOWN
Royal North Shore Hospital
OTHER
Henning Bundgaard
OTHER